IBRX
ImmunityBio, Inc. · Search Wikipedia for ImmunityBio, Inc. · Yahoo Finance chart ↗
Price
- Last close
- $8.93Last update Nov 4, 2026
- 12-month high
- $12.43
- 12-month low
- $1.95
Reported holders
Politicians whose newest complete holdings report lists this stock, or who reported buying it after that report (or at any time, if they have no usable report). A later full sale that could have closed the position removes them.
| Name | Purchased | Price that day | ROI |
|---|---|---|---|
| Lisa McClain Rank #2 | Sep 30, 2026 | $9.44 | -5.40% |
Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close.
All trades
| Ticker | Politician Name | Transaction Type | Trade Date | Found Date |
|---|---|---|---|---|
| IBRX — ImmunityBio, Inc. - Common Stock (IBRX) [ST], Lisa McClain, purchase, Sep 30, 2026 | Lisa McClain Rank #2 | Purchase | Sep 30, 2026 | Oct 19, 2026 |
| IBRX — ImmunityBio, Inc. - Common Stock (IBRX) [ST], Lisa McClain, purchase, Sep 28, 2026 | Lisa McClain Rank #2 | Purchase | Sep 28, 2026 | Oct 19, 2026 |
| IBRX — ImmunityBio, Inc. (IBRX) [ST], Daniel Goldman, sale, Mar 6, 2023 | Daniel Goldman Rank #98 | Sale | Mar 6, 2023 | Sep 12, 2026 |